February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla's Energy Unit Emerges as a Growth Catalyst
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Protagonist Therapeutics (PTGX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: March 19, 2025 (16:31)
Sector: HealthcareThe share price of Protagonist Therapeutics, Inc. (PTGX) now
Are you interested in Protagonist Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Protagonist Therapeutics stock price in 2025, 2026, 2027. How much will one Protagonist Therapeutics share be worth in 2025 - 2027?
When should I take profit in Protagonist Therapeutics stock? When should I record a loss on Protagonist Therapeutics stock? What are analysts' forecasts for Protagonist Therapeutics stock? What is the future of Protagonist Therapeutics stock? We forecast Protagonist Therapeutics stock performance using neural networks based on historical data on Protagonist Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Protagonist Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Protagonist Therapeutics shares. This happens once a day.
Historical and forecast chart of Protagonist Therapeutics stock
The chart below shows the historical price of Protagonist Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Protagonist Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
“Protagonist Therapeutics, Inc.” is a clinical stage biopharmaceutical company with a peptide technology platform focused on the discovery and development of new chemical entities (NECs) to meet significant unmet medical needs. The Company’s product pipeline includes PTG-100, PTG-200 and PTG-300. His main focus is on the development of oral peptide formulations that target biological pathways, also targeting commercially available injectable antibodies. PTG-100 is an oral peptide product of an alpha-4-beta-7 (a4b7) integrin antagonist candidate who has completed a phase I clinical trial in normal healthy volunteers (NHVs). PTH-100 is being developed for the treatment of moderate to severe ulcerative colitis (UC). PTG-200 is an oral interleukin-23 (IL-23R) receptor antagonist being developed for the treatment of moderate to severe Crohn’s disease. PTG-300 is an injectable hepcidin mimetic for the treatment of rare conditions associated with iron overload.
Protagonist Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar 21 | 55.09 | 54.29 | 56.13 | 3.38 |
| Mar 22 | 55.04 | 53.75 | 55.55 | 3.35 |
| Mar 23 | 55.80 | 55.43 | 56.75 | 2.39 |
| Mar 24 | 54.37 | 53.36 | 55.02 | 3.12 |
| Mar 25 | 54.11 | 52.89 | 54.94 | 3.87 |
| Mar 26 | 54.11 | 53.58 | 55.07 | 2.79 |
| Mar 27 | 54.83 | 54.20 | 56.12 | 3.55 |
| Mar 28 | 55.04 | 53.72 | 56.03 | 4.30 |
| Mar 29 | 55.11 | 54.16 | 55.67 | 2.78 |
| Mar 30 | 53.88 | 53.17 | 54.63 | 2.74 |
| Mar 31 | 53.11 | 52.09 | 54.03 | 3.73 |
| Apr 01 | 53.58 | 53.07 | 54.55 | 2.79 |
| Apr 02 | 55.06 | 54.10 | 55.39 | 2.38 |
| Apr 03 | 55.01 | 54.37 | 55.41 | 1.91 |
| Apr 04 | 54.42 | 53.60 | 55.28 | 3.14 |
| Apr 05 | 55.59 | 54.33 | 55.93 | 2.95 |
| Apr 06 | 56.10 | 55.19 | 56.90 | 3.11 |
| Apr 07 | 57.16 | 56.08 | 58.46 | 4.25 |
| Apr 08 | 57.94 | 57.20 | 58.95 | 3.07 |
| Apr 09 | 57.65 | 57.18 | 58.10 | 1.60 |
| Apr 10 | 58.36 | 57.88 | 58.81 | 1.60 |
| Apr 11 | 56.71 | 56.17 | 58.04 | 3.33 |
| Apr 12 | 57.12 | 56.40 | 57.65 | 2.22 |
| Apr 13 | 58.27 | 57.32 | 59.61 | 3.99 |
| Apr 14 | 58.65 | 57.49 | 59.20 | 2.97 |
| Apr 15 | 59.34 | 58.68 | 60.16 | 2.52 |
| Apr 16 | 57.58 | 56.44 | 58.60 | 3.83 |
| Apr 17 | 57.72 | 56.36 | 58.37 | 3.56 |
| Apr 18 | 57.46 | 56.77 | 58.82 | 3.61 |
| Apr 19 | 57.06 | 55.84 | 57.59 | 3.13 |
Protagonist Therapeutics Daily Price Targets
Protagonist Therapeutics Stock Forecast 03-21-2025.
Forecast target price for 03-21-2025: $55.09.
Positive dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.268%.
Pessimistic target level: 54.29
Optimistic target level: 56.13
Protagonist Therapeutics Stock Forecast 03-22-2025.
Forecast target price for 03-22-2025: $55.04.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.240%.
Pessimistic target level: 53.75
Optimistic target level: 55.55
Protagonist Therapeutics Stock Forecast 03-23-2025.
Forecast target price for 03-23-2025: $55.80.
Positive dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 2.330%.
Pessimistic target level: 55.43
Optimistic target level: 56.75
Protagonist Therapeutics Stock Forecast 03-24-2025.
Forecast target price for 03-24-2025: $54.37.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.024%.
Pessimistic target level: 53.36
Optimistic target level: 55.02
Protagonist Therapeutics Stock Forecast 03-25-2025.
Forecast target price for 03-25-2025: $54.11.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.723%.
Pessimistic target level: 52.89
Optimistic target level: 54.94
Protagonist Therapeutics Stock Forecast 03-26-2025.
Forecast target price for 03-26-2025: $54.11.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 2.712%.
Pessimistic target level: 53.58
Optimistic target level: 55.07
PTGX (PTGX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr. | 41.29 | 37.97 | 42.92 | 11.54 |
| May. | 41.04 | 38.92 | 43.16 | 9.81 |
| Jun. | 41.93 | 39.71 | 45.50 | 12.72 |
| Jul. | 37.00 | 35.75 | 39.66 | 9.85 |
| Aug. | 34.42 | 32.15 | 35.66 | 9.85 |
| Sep. | 38.43 | 37.32 | 41.89 | 10.90 |
| Oct. | 38.29 | 37.28 | 39.99 | 6.78 |
| Nov. | 38.89 | 36.65 | 41.78 | 12.29 |
| Dec. | 41.13 | 38.56 | 43.15 | 10.64 |
Protagonist Therapeutics forecast for this year
Protagonist Therapeutics Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $41.2889. Pessimistic: $37.97. Optimistic: $42.92
Protagonist Therapeutics Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $41.0411. Pessimistic: $38.92. Optimistic: $43.16
Protagonist Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $41.9276. Pessimistic: $39.71. Optimistic: $45.50
Protagonist Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $36.9969. Pessimistic: $35.75. Optimistic: $39.66
Protagonist Therapeutics Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $34.4219. Pessimistic: $32.15. Optimistic: $35.66
Protagonist Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $38.4286. Pessimistic: $37.32. Optimistic: $41.89
Protagonist Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $38.2903. Pessimistic: $37.28. Optimistic: $39.99
Protagonist Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $38.8876. Pessimistic: $36.65. Optimistic: $41.78
Protagonist Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $41.1276. Pessimistic: $38.56. Optimistic: $43.15
Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 42.31 | 41.14 | 43.78 | 6.03 |
| Feb | 37.49 | 36.41 | 41.04 | 11.29 |
| Mar | 38.34 | 36.23 | 40.74 | 11.07 |
| Apr | 40.97 | 39.98 | 43.03 | 7.08 |
| May | 45.14 | 42.16 | 48.45 | 12.97 |
| Jun | 43.14 | 41.64 | 45.68 | 8.84 |
| Jul | 45.42 | 43.40 | 49.72 | 12.71 |
| Aug | 49.72 | 45.19 | 53.18 | 15.03 |
| Sep | 52.59 | 47.67 | 54.04 | 11.79 |
| Oct | 49.56 | 47.42 | 53.96 | 12.12 |
| Nov | 51.64 | 50.21 | 55.17 | 8.99 |
| Dec | 51.95 | 49.21 | 53.51 | 8.04 |
Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 53.51 | 51.58 | 54.99 | 6.19 |
| Feb | 51.97 | 48.72 | 53.53 | 8.97 |
| Mar | 55.27 | 50.89 | 57.39 | 11.33 |
| Apr | 57.00 | 52.55 | 58.71 | 10.49 |
| May | 54.53 | 52.64 | 58.79 | 10.46 |
| Jun | 57.87 | 56.07 | 61.14 | 8.29 |
| Jul | 54.26 | 50.16 | 57.71 | 13.09 |
| Aug | 48.40 | 44.16 | 50.72 | 12.94 |
| Sep | 46.31 | 44.03 | 47.81 | 7.90 |
| Oct | 43.14 | 39.62 | 45.99 | 13.85 |
| Nov | 44.70 | 40.78 | 45.93 | 11.21 |
| Dec | 47.48 | 43.15 | 51.42 | 16.07 |
Protagonist Therapeutics information and performance
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US
Market capitalization of the Protagonist Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of PTGX shares in the company outstanding by the market price of one share.
EBITDA of Protagonist Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Protagonist Therapeutics Stock)
Should I Buy Protagonist Therapeutics Shares in 2025 year?
Does Protagonist Therapeutics pay dividends?
Which economic sector do Protagonist Therapeutics's shares belong to?
Which other securities belong to the same sector as Protagonist Therapeutics's shares?
